Compile Data Set for Download or QSAR
Report error Found 181 Enz. Inhib. hit(s) with all data for entry = 12778
LigandPNGBDBM728118((Z)-1-acetyl-2-((4- (naphthalen-1-yl)- 6-(4-(oxeta...)
Affinity DataIC50: 300nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728110((Z)-2-((4-(3-(1H- pyrazol-4-yl)phen- yl)-6-(morpho...)
Affinity DataIC50: 300nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728111((Z)-1-acetyl-2- ((4-(3-(1-methyl- 1H-pyrazol-4-yl)...)
Affinity DataIC50: 300nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728061((Z)-2-((4-([1,1'- biphenyl]-2-yl)-6- (4-(2-hydroxy...)
Affinity DataIC50: 350nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728160((Z)-1-acetyl-2- ((4-(2-acetyl- 1,2,3,4-tetrahydro-...)
Affinity DataIC50: 400nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728126((Z)-1-acetyl-2-((4- (1-methyl-1H- pyrazol-4-yl)-6-...)
Affinity DataIC50: 400nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728127((Z)-1-acetyl-2- ((4-(2-methyl- 1,2,3,4-tetrahydro-...)
Affinity DataIC50: 400nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728075((E)-1-acetyl-2- ((5-((E)-3-morph- olino-3-oxoprop-...)
Affinity DataIC50: 420nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728060((Z)-2-((4-([1,1'- biphenyl]-2-yl)-6- (4-(oxetan-3-...)
Affinity DataIC50: 440nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728074((Z)-1-acetyl-2- ((5-((E)-3-morph- olino-3-oxoprop-...)
Affinity DataIC50: 460nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728090((Z)-4-([1,1'- biphenyl]-2-yl)-2- ((1-acetyl-3-oxo-...)
Affinity DataIC50: 490nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728055((Z)-2-((4-([1,1'- biphenyl]-2-yl)-6- (morpholine-4...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728128((Z)-4-(2-((1-acetyl- 3-oxoindolin-2- ylidene)methy...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728129((Z)-3-(2-((1-acetyl- 3-oxoindolin-2- ylidene)methy...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728108((Z)-1-acetyl-2- ((4-(2-acetyl- 1,2,3,4-tetra- hydr...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728141((Z)-1-acetyl-2- ((4-(2-acetyl- 1,2,3,4-tetra- hydr...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728125((Z)-1-acetyl-2- ((6-(morpholine- 4-carbonyl)-4- (1...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728109(6-(2-((1-acetyl-3- oxoindolin-2- ylidene)methyl)- ...)
Affinity DataIC50: 500nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728062((Z)-4-([1,1'- biphen-yl]-2-yl)- 2-((1-acetyl-3- ox...)
Affinity DataIC50: 510nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728077((Z)-2-((4-((3H- [1,2,3]triazolo [4,5-b]pyridin-3- ...)
Affinity DataIC50: 550nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728024((E)-N-((2-((1- acetyl-3-oxoin- dolin-2-ylidene)- m...)
Affinity DataIC50: 570nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728050((Z)-1-acetyl-2- ((4-butoxy-6- (morpholine-4- carbo...)
Affinity DataIC50: 580nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728051((Z)-1-acetyl-2- ((6-(morpholine- 4-carbonyl)-4- (p...)
Affinity DataIC50: 580nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728116((Z)-2-((1-acetyl- 3-oxoindolin-2- ylidene)methyl)-...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728162((Z)-1-acetyl-2-((4- (2-acetyl-1,2,3,4- tetrahydroi...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728161((Z)-1-acetyl-2-((4- (3-(1-methyl-1H- pyrazol-4-yl)...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728154((Z)-1-acetyl-2- ((4-(1-methyl-1H- pyrazol-4-yl)qui...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728107(2-((4-(1H-indazol- 4-yl)-6-(morph- oline-4-carbony...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728105((Z)-2-((4-([1,1'- biphenyl]-2-yl)-6- (((tetrahydro...)
Affinity DataIC50: 600nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728048((Z)-1-acetyl-2- ((4-chloro-6- (morpholine-4- carbo...)
Affinity DataIC50: 610nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728059(1-acetyl-2-((6- (morpholine-4- carbonyl)-4-(2- phe...)
Affinity DataIC50: 660nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728078((Z)-N-(2-((1- acetyl-3-oxoin- dolin-2-ylidene)- me...)
Affinity DataIC50: 680nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728063((Z)-1-acetyl-2- ((5-(2,6-dimethyl- morpholine-4- c...)
Affinity DataIC50: 680nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728114((Z)-2-((1-acetyl- 3-oxoindolin-2- ylidene)methyl)-...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728147((Z)-1-acetyl-2- ((4-(2-acetyl- 1,2,3,4-tetra- hydr...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728158(1-acetyl-2-((4-(2- acetyl-1,2,3,4- tetrahydroisoqu...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728156((Z)-1-acetyl-2- ((4-(1-methyl-1H- pyrazol-4-yl)-6-...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728120((Z)-1-acetyl-2- ((4-(naphthalen-2- yl)-6-(4-(oxeta...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728025((E)-1-acetyl-2- ((6-(morpholine- 4-carbonyl)benzo ...)
Affinity DataIC50: 700nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728040((Z)-1-acetyl-2- ((6-((4-(oxetan- 3-yl)piperazin-1-...)
Affinity DataIC50: 710nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728083(1-acetyl-2-((6- (morpholine-4- carbonyl)-4-(naph- ...)
Affinity DataIC50: 730nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728014((Z)-1-acetyl-2- ((6'-(morpholine- 4-carbonyl)-[3,4...)
Affinity DataIC50: 760nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728065((Z)-1-acetyl-2- ((6-(2,6-dimethyl- morpholine-4- c...)
Affinity DataIC50: 770nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728066((E)-1-acetyl-2- ((6-(2,6-dimethyl- morpholine-4- c...)
Affinity DataIC50: 780nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728064((E)-1-acetyl-2-((5- (2,6-dimethylmor- pholine-4-ca...)
Affinity DataIC50: 780nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728097((E)-1-acetyl-2- ((6-(((tetrahydro- 2H-pyran-4-yl)-...)
Affinity DataIC50: 790nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728150((Z)-1-acetyl-2-((4- (2-(1-methyl-1H- pyrazol-4-yl)...)
Affinity DataIC50: 800nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728132((Z)-1-acetyl-2-((4- (1-ethyl-1H-pyr- azol-4-yl)-6-...)
Affinity DataIC50: 800nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728117((Z)-2-((4-([1,1'- biphenyl]-3-yl)-6- (4-(oxetan-3-...)
Affinity DataIC50: 800nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

LigandPNGBDBM728146((Z)-1-acetyl-2- ((4-(1-methyl- 1H-imidazol-4- yl)-...)
Affinity DataIC50: 800nMAssay Description:The in vitro Ras-Raf binding inhibitory activity of the compound of the present invention was evaluated by an ELISA method described below. GST-c-Raf...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 181 total ) | Next | Last >>
Jump to: